Changes in renal function have been reported in chronic obstructive lung disease' but not proteinuria. We describe a heterogeneous group of patients with chronic obstructive lung disease who were found to have microalbuminuria. 
The average age ofthe patients with chronic obstructive lung disease was 72 years (range 57-85), and the disease had been present for a mean of 20 years (range 2-50). Mean values for carbon dioxide tension and oxygen pressure were 5-7 (range 4-2 to 9 3) and 9 1 (4 9 to 17 1) kPa respectively. Forced vital capacity averaged 1 8 (0-6 to 3 0) litres, and forced expiratory volume in one second/forced vital capacity was 54% (28-91%). Nine patients had clinical and electrocardiographic evidence of cor pulmonale.
No sample had evidence of haematuria, glycosuria, or lysozyme. The excretion of albumin was significantly higher in the chronic obstructive lung disease group. The distribution of -y-glutamyltransferase and P3-N-acetylglucosaminidase levels was similar (figure).
In the chronic obstructive lung disease group there was a highly significant relation between y-glutamyltransferase and 3-N-acetylglucosaminidase levels (r-0*681; p=0 001) but not between either of these levels and albumin. The excretion of these markers was not related to age, forced expiratory volume in one second, forced vital capacity, forced expiratory volume in one second/forced vital capacity, or arterial oxygen pressure, but there was a significant relation between arterial carbon dioxide tension and -y-glutamyltransferase level (r-0-55; p=0 01). Patients with evidence of cor pulmonale did not form a distinct subgroup.
Comment
This preliminary study suggests that proteinuria may be a feature of chronic obstructive lung disease. On average the excretion was doubled, but there was a wide scatter of results; in half the patients values were normal. The appearance of albumin (a large protein) in the urine but the virtual absence of lysozyme (a small protein) suggests that the proteinuria is glomerular. A similar proteinuria has been described in chronic sleep apnoea and at high altitude.23 In both cases the protein leak was attributed to increased glomerular permeability as a result of tissue hypoxia. Whether this is so in chronic obstructive lung disease is not known.
In chronic obstructive lung disease both atrial natriuretic peptide4 and glomerular size5 are increased, which would favour increased filtration. Polypharmacy is common but the renal effect is difficult to assess and impossible to control. There was no unique combination of drugs or class of drugs associated with high renal loss of albumin or enzymes. The enzymuria may reflect tissue hypoxia, renal hypertrophy, or smoking history.
Further longitudinal studies are needed to determine whether these changes are progressive or have any prognostic relevance.
